ARCHIVE

• EAD Director Calls on Makers to Reduce Invoice Prices
  February 18, 2002

• Sugi Pharmacy's Ordinary Profits to Jump 40%: Okasan Securities
  February 18, 2002

• Safety Measures Must Be Coordinated with Global Standards: Korosho Official
  February 18, 2002

• Tokai Tokyo Research Forecasts Continued Growth for Matsumotokiyoshi
  February 18, 2002

• Requirements for Biologic Products, Antibiotics Revised
  February 18, 2002

• RESEARCH AND DEVELOPMENT NEWS IN BRIEF
  February 18, 2002

• 30% Hike of Copayment Agreed
  February 18, 2002

• Korosho to Review Drug Reevaluation System
  February 18, 2002

• WORLD NEWS IN BIREF
  February 18, 2002

• Hayashibara's IFN-a to Be Approved in South Korea
  February 18, 2002

• REGULATORY NEWS IN BRIEF
  February 18, 2002

• Japanese Global Strategy Update (7)
  February 18, 2002

• Slowdown of Buying Activities Not Seen in Market
  February 18, 2002

• Kusuri Proverbs Reveal Japanese Spirit (3)
  February 18, 2002

• Chugai Transfers Marketing Rights of Keiten to Fujisawa
  February 18, 2002

• Drug Makers Should Conclude Labor Contracts with Hospitals for PMS: Pharmacy Expert
  February 18, 2002

• Novartis Transfers Marketing Rights for Halospor to Toyama
  February 18, 2002

• Use of Computers for Processing Medical Bills to Be Promoted
  February 18, 2002

• Marketing Suspension of Berotec Aerosol Requested by Medwatcher Japan
  February 18, 2002

• JMA Committee Opposed to Increases in Copayment
  February 18, 2002

ページ

• « 先頭
• ‹ Prev
• …
• 699
• 700
• 701
• 702
• 703
• 704
• 705
• 706
• 707
• …
• Next ›
• 最終 »